treprostinil diolamine

treprostinil diolamine (OREPAXAM) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

OREPAXAM is a marketed brand name for treprostinil diolamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

treprostinil diolamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.